DiaMedica Therapeutics Inc.

DMAC | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.39

+$0.13 (+1.79%)

Sep 22, 2026, 11:52 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-32.77M	-24.44M	-19.38M	-13.68M	-13.59M	-12.29M
Depreciation & Amortization	-899K	39K	30K	25K	24K	21K
Stock-Based Compensation	3.85M	2.09M	1.68M	1.5M	1.56M	1.84M
Other Working Capital	162K	1.37M	188K	312K	-81K	-205K
Other Non-Cash Items	82K	-1.27M	-1.15M	53K	219K	48K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	675K	1.51M	93K	585K	-461K	1.2M
Operating Cash Flow	-29.06M	-22.08M	-18.73M	-11.51M	-12.25M	-9.19M
Capital Expenditures	-40K	-25K	-24K	-81K	-22K	-47K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-59.28M	-50.41M	-69.41M	-45.68M	-69.81M	-39.75M
Sales Maturities Of Investments	57.13M	59M	51.14M	57.3M	49.3M	23.64M
Other Investing Acitivies	n/a	n/a	n/a	n/a	2K	16K
Investing Cash Flow	-2.19M	8.56M	-18.3M	11.54M	-20.54M	-16.13M
Debt Repayment	-10K	-9K	-6K	-6K	-6K	-5K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-400K	256K	n/a	n/a	244K	45K
Financial Cash Flow	43.88M	11.99M	36.84M	-6K	30.09M	28.85M
Net Cash Flow	12.62M	-1.52M	-185K	21K	-2.7M	3.53M
Free Cash Flow	-29.1M	-22.1M	-18.75M	-11.59M	-12.27M	-9.23M
Adj. Free Cash Flow	-32.95M	-24.19M	-20.44M	-13.09M	-13.83M	-11.08M
Maintenance CapEx	-40K	-25K	-24K	-81K	-22K	-47K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-29.1M	-22.1M	-18.75M	-11.59M	-12.27M	-9.23M